<DOC>
	<DOC>NCT01959932</DOC>
	<brief_summary>The overall goal of the study is to evaluate if the ad libitum use of the Tobacco Heating System 2.2 (THS 2.2) for 5 days by adult healthy smokers results in a reduction in the levels of biomarkers of exposure (BoExp) for selected harmful and potentially harmful constituents (HPHCs) compared to smoking conventional cigarettes (CC) and smoking abstinence (SA).</brief_summary>
	<brief_title>Reduced Exposure Study in Smokers Using THS 2.2 With 5 Days in a Confinement Setting.</brief_title>
	<detailed_description />
	<criteria>Subject is Caucasian. Current healthy smoker as judged by the Principal Investigator. Subject has smoked at least 10 commercially available nonmenthol CCs per day (no brand restrictions) for the last 4 weeks. Subject has smoked for at least the last 3 consecutive years. Subject does not plan to quit smoking in the next 3 months. As per Investigator judgment, the subject cannot participate in the study for any reason (e.g., medical, psychiatric, and/or social reason). Subject has received medication within 14 days or within 5 halflives of the medication (whichever is longer), which has an impact on cytochrome P450 1A2 (CYP1A2) or cytochrome P450 2A6 (CYP2A6) activity. Female subject is pregnant or breast feeding. Female subject does not agree to use an acceptable method of effective contraception.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Smoking</keyword>
	<keyword>Candidate Modified Risk Tobacco Product</keyword>
	<keyword>Conventional cigarettes</keyword>
	<keyword>Reduced exposure</keyword>
	<keyword>Confinement</keyword>
</DOC>